Dr Cyrus Desouza reviews GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT2 inhibitors, offering advice on which patients may benefit from each class.

Dr Gerald Chodak reviews new data on active surveillance for low-risk prostate cancer and its effect on metastasis-free and prostate cancer-specific survival.

Here are the hot-off-the-press revisions to CDC contraception guidelines and recommendations.

Dr Arefa Cassoobhoy highlights one of the week's important news stories for primary care.

Join Drs Vega and Anawalt as they discuss hot topics from ENDO 2017, including a new drug class for hot flashes and management of subclinical hypothyroidism in older adults.

When it comes to national healthcare, 'open your eyes' to international models and 'be not afraid to change,' advises Dr George Lundberg.

Physicians from all over the country tell Medscape about their experiences with the ACA. What's your take?

Dr Judi Miller explains easy ways to improve these patients' encounters.

For patients, knowing whether their kidney function is compromised and telling their doctor about it goes a long way toward preventing medication errors and complications.

Dr Kenny Lin explains how new data support a more measured approach to diagnosing and treating osteoporosis.